A study conducted at Turku PET Center in Finland showed that changes in the functioning of opioid neurotransmitters in the ...

Discover how changes in opioid neurotransmitters in the brain may influence anorexia nervosa, affecting appetite, anxiety, ...

New research found that individuals with anorexia nervosa have elevated opioid neurotransmitter activity, which may contribute to appetite loss and emotional symptoms. A study from the Turku PET Centr ...

A study showed that changes in the functioning of opioid neurotransmitters in the brain may underlie anorexia.

Tris Pharma has pointed to a phase 3 win for its pain relief drug as demonstrating the candidate’s potential to help resolve the opioid crisis. | Tris Pharma has pointed to a phase 3 win for its pain ...

Naloxone is a commonly administered drug used to reverse the effects of an opioid overdose. It works by binding to opioid ...

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous ...

Are dropping fentanyl-related death rates concealing other issues in the fight against this brutal form of addiction?

A study conducted at Turku PET Centre in Finland showed that changes in the functioning of opioid neurotransmitters in the brain may underlie anorexia.

Accordingly, opioid abuse has become a problem of epidemic proportions in the United States and throughout much of the world. The International Narcotics Research Conference has held annual meetings ...

Ideas, insights and resources to inspire opioid stewardship. The use and misuse of opiate-based prescription, synthetic and illicit drugs, are a major public health concern. In 2021, 107,622 lives ...